Psychiatry: Clinical Research and Personalized Medicine
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Personalized Therapy in Clinical Medicine".
Deadline for manuscript submissions: 25 September 2026
Special Issue Editor
Special Issue Information
Dear Colleagues,
Personalized therapy in clinical psychiatry has emerged as a transformative approach to mental health care, driven by advances in genomics, neuroimaging, and digital health technologies. Historically, psychiatric treatment relied on standardized protocols, but the recognition of individual variability in genetic, biological, and environmental factors has shifted the paradigm toward tailored interventions. This call for papers invites submissions for a Special Issue focused on advancing personalized therapy in clinical psychiatry. We aim to explore innovative strategies that enhance treatment efficacy and patient outcomes through individualized approaches. The scope of this issue includes, but is not limited to, cutting-edge research in pharmacogenomics, biomarker-driven therapies, machine learning applications for treatment prediction, and digital phenotyping for real-time monitoring.
We solicit original research articles and reviews that address novel methodologies, clinical trials, ethical considerations, or implementation challenges in personalized psychiatric care. Submissions should contribute to the growing evidence base for precision psychiatry and its potential to revolutionize mental health treatment.
Dr. Georgios Floros
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- personalized therapy
- clinical psychiatry
- pharmacogenomics
- biomarker-driven therapies
- machine learning
- digital phenotyping
- precision psychiatry
- mental health
- individualized treatment
- neuroimaging
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
